Browse medication monographs, dosing guides, contraindications, interactions, and pharmacology-focused articles.
According to a 2023 review of six studies, Ozempic (semaglutide) significantly reduced blood pressure in individuals with and without type 2 diabetes. This effect highlights an important cardiovascular benefit for a medication primarily prescribed for diabetes management, addressing the question: **Can Ozempic lower your blood pressure?**
Read MoreNearly half of adults in the U.S. have hypertension, a condition that can lead to life-threatening emergencies. When blood pressure spikes to dangerous levels, the question of **which injection lowers blood pressure** quickly becomes critical for medical teams.
Read MoreAccording to a 2021 meta-analysis published in *Hypertension*, the long-held belief that beta-blockers cause depression was not supported by evidence from double-blind, randomized controlled trials. However, there are still several important reasons **why you should avoid beta-blockers** in certain medical situations, from specific health conditions to potential adverse effects that require careful management.
Read MoreApproximately 0.1% to 1% of patients taking Ramipril may experience pruritus, or itching, as an uncommon side effect. This makes it essential for patients to understand how and why can Ramipril cause itching and how to recognize signs that may signal a more serious allergic reaction.
Read MoreOrthostatic hypotension affects a significant portion of the elderly population and can be severely debilitating. While single-agent therapy often works, some patients with refractory cases require a combination approach to manage symptoms effectively. For these individuals, the question often arises: **Can midodrine and fludrocortisone be taken together**?
Read MoreIn 2023, ramipril was one of the most prescribed medications in the United States, with over 2 million prescriptions [1.2.2]. However, it's not suitable for everyone. Understanding who should avoid ramipril is crucial for patient safety and efficacy [1.3.2].
Read MoreAs of 2022, approximately 150 million people worldwide use metformin daily, making it a first-choice drug for type 2 diabetes [1.10.3]. If you're one of them, you may be asking, 'How do I know if I still need metformin?'
Read MoreControlled hypotension can significantly reduce intraoperative blood loss and the need for blood transfusions during major spinal surgeries. This medically induced state of lower-than-normal blood pressure is a carefully managed procedure performed by an anesthesia team to improve surgical conditions and enhance patient outcomes.
Read MoreFor patients in septic shock, immediate treatment with a vasopressor is critical after fluid resuscitation to correct hypotension. While the specific choice depends on the underlying cause, norepinephrine is widely considered the first drug of choice for hypotension in many acute and severe conditions. This guideline reflects its potent and reliable effects on blood pressure and is a cornerstone of critical care practice.
Read MoreWhile the utilization of tPA for ischemic stroke in the U.S. increased to 10.2% by 2018, many patients are ineligible because they arrive outside the treatment window. The core question remains: why can't you use tPA after 3 hours for most patients?
Read MoreWith over 68 million prescriptions filled in the United States in 2023, amlodipine is one of the most commonly prescribed medications. The answer to the question, "Is amlodipine a calcium channel blocker?", is a definitive yes, making it a key player in treating cardiovascular conditions like high blood pressure and angina.
Read MoreMedical trials have shown that targeting hemoglobin levels higher than a certain threshold with erythropoiesis-stimulating agents (ESAs) like Epogen can increase the risk of serious cardiovascular events and stroke in patients with chronic kidney disease. These significant risks have reshaped the modern guidelines for Epogen hemoglobin therapy, moving the focus from aggressive normalization to conservative management aimed at reducing the need for blood transfusions.
Read More